Tag: Cancer: Mouth
High CVD Risk in Patients With Head, Neck Squamous Cell Cancer
Twenty-three and 24 percent of patients had CVD and uncontrolled blood pressure at diagnosis
Cancer Cachexia Associated With Poor Outcomes
Findings at six and 12 months after treatment for advanced head and neck cancer
Radiation Dose to Head & Neck Tied to Thyroid Dysfunction Risk
Findings in patients with head and neck cancer receiving RT; female sex, concurrent chemo up risk
Microsurgical Head and Neck Reconstruction Is Cost-Effective
Cost-effective versus locoregional flaps for all stages of SCC, especially in early-stage cancer
Review: Methodological Limitations for OSCC Biomarkers
Limitations include lack of methodological criteria within studies, lack of consensus on marker choices
Nivolumab Ups Overall Survival in Head, Neck Cancer
Longer overall survival compared with single-agent therapy for platinum-refractory squamous-cell cancer
Shorter Duration of Feeding Tube Placement With IMRT
Findings among patients with head and neck cancer undergoing definitive intensity modulated RT
Nonsurgical Therapy Increasing for Advanced Oral Cavity SCC
Surgical therapy linked to significantly improved mean disease-specific and overall survival
Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis
Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis
Elective Neck Dissection Cost-Effective in Oral Cavity Cancer
Addition of elective neck dissection to primary surgery reduces costs, improves effectiveness